WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.

Examples of Hemolyzed, Icteric, and Lipemic/Turbid Samples Quick Guide

View Sample Pages

CLSI C56AQG

Examples of Hemolyzed, Icteric, and Lipemic/Turbid Samples Quick Guide

This Quick Guide shows examples of hemolyzed, icteric, and lipemic/turbid samples. Formatted as a durable, waterproof sheet for quick reference.

This document is available only in electronic format.

Member price:

List Price:
Log in/sign up to see price and add to cart

Details

Date of Publication: July 13, 2012

Order Code PDF: CLSI C56AQGE

Order Code Print: print not available

Pages: 1

CLSI C56AQG Abstract

Clinical and Laboratory Standards Institute document C56-A—Hemolysis, Icterus, and Lipemia/Turbidity Indices as Indicators of Interference in Clinical Laboratory Analysis; Approved Guideline focuses on the intended usefulness and challenging issues of hemolysis, icterus, and lipemia/turbidity (HIL) indices as estimates of interference that may impact the validity and clinical utility of reportable patient results. C56 is closely aligned with CLSI document EP071; thus, the basic concepts for interference testing are briefly discussed in C56 to gain an understanding of the process by which HIL alert indices are established. Automated HIL systems currently available from various manufacturers are also described. This document enhances the continuous education of health care personnel by explaining the mechanisms of HIL interference, which in some cases include the noncorrelation of visual and (semi)quantitative HIL indices, the strengths and limitations of HIL measurements, and the verification of HIL indices in the clinical laboratory.

Back to Top

CLSI uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our privacy policy.

Accept